News

Patients with sleep apnea receiving pulmonary rehabilitation had 34% lower all-cause mortality than similar patients who did not receive PR.
In medical thoracoscopy, the pleural access success rate was lower in patients with vs without prior artificial pneumothorax ...
Triple therapy for COPD is more likely to offer cardiopulmonary benefits vs dual therapy, as indicated by NNT estimates for key cardiac outcomes.
Allergic and/or T2 inflammatory biomarkers are more common in patients with asthma or asthma-COPD overlap vs in patients with COPD alone.
Small airways disease and emphysema are associated with pollution exposure in those with a long smoking history and no airflow obstruction.
Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.
HealthDay News — The U.S. Department of Health and Human Services and U.S. Food and Drug Administration have begun to comprehensively review the nutritional value of infant formula, a program the ...
The FDA has announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.
US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025.
The HHS has announced a plan to reduce regulations, stating that, for every new regulation introduced, at least 10 existing regulations must be eliminated.
Zongertinib conferred a clinically meaningful benefit in patients with previously treated, advanced, HER2-mutant NSCLC in a phase 1 trial.